Skip to main content
Journal of Oncology logoLink to Journal of Oncology
. 2020 Mar 31;2020:8947367. doi: 10.1155/2020/8947367

Corrigendum to “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation”

D Brocco 1, P Lanuti 2,3, P Simeone 2,3, G Bologna 2,3, D Pieragostino 3,4, M C Cufaro 3,4, V Graziano 5,6, M Peri 1, P Di Marino 1, M De Tursi 6, A Grassadonia 6, I G Rapposelli 7, L Pierdomenico 2,3, E Ercolino 2,3, F Ciccocioppo 2,3, P Del Boccio 3,8, M Marchisio 2,3,, C Natoli 6, S Miscia 2,3, N Tinari 6
PMCID: PMC7150712  PMID: 32318109

In the article titled “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation” [1], the author Piero del Boccio was affiliated to Department of Medical, Oral and Biotechnological Sciences, University “G. D'Annunzio” of Chieti-Pescara, Analytical Biochemistry and Proteomics Laboratory, Chieti, Italy, which is incorrect. The corrected list of affiliations is shown above.

References

  • 1.Brocco D., Lanuti P., Simeone P., et al. Circulating cancer stem cell-derived extracellular vesicles as a novel biomarker for clinical outcome evaluation. Journal of Oncology. 2019;2019:13. doi: 10.1155/2019/5879616.5879616 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Oncology are provided here courtesy of Wiley

RESOURCES